AR016233A1 - Tienopirimidinas, un procedimiento para su preparacion, el empleo de las mismas para preparar un medicamento, las composiciones farmaceuticas que lascontienen, y un procedimiento para obtener estas composiciones farmaceuticas. - Google Patents
Tienopirimidinas, un procedimiento para su preparacion, el empleo de las mismas para preparar un medicamento, las composiciones farmaceuticas que lascontienen, y un procedimiento para obtener estas composiciones farmaceuticas.Info
- Publication number
- AR016233A1 AR016233A1 ARP990101960A ARP990101960A AR016233A1 AR 016233 A1 AR016233 A1 AR 016233A1 AR P990101960 A ARP990101960 A AR P990101960A AR P990101960 A ARP990101960 A AR P990101960A AR 016233 A1 AR016233 A1 AR 016233A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- procedure
- preparation
- phosphodiesterase
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- -1 COOA Chemical group 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 208000030499 combat disease Diseases 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002993 cycloalkylene group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19819023A DE19819023A1 (de) | 1998-04-29 | 1998-04-29 | Thienopyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016233A1 true AR016233A1 (es) | 2001-06-20 |
Family
ID=7866082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101960A AR016233A1 (es) | 1998-04-29 | 1999-04-28 | Tienopirimidinas, un procedimiento para su preparacion, el empleo de las mismas para preparar un medicamento, las composiciones farmaceuticas que lascontienen, y un procedimiento para obtener estas composiciones farmaceuticas. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6495557B1 (https=) |
| EP (1) | EP1084125B1 (https=) |
| JP (1) | JP4242561B2 (https=) |
| KR (1) | KR20010042628A (https=) |
| CN (1) | CN1142936C (https=) |
| AR (1) | AR016233A1 (https=) |
| AT (1) | ATE314374T1 (https=) |
| AU (1) | AU743230B2 (https=) |
| BR (1) | BR9910032A (https=) |
| CA (1) | CA2328280C (https=) |
| CO (1) | CO5011050A1 (https=) |
| CZ (1) | CZ291109B6 (https=) |
| DE (2) | DE19819023A1 (https=) |
| ES (1) | ES2255754T3 (https=) |
| HU (1) | HUP0101832A3 (https=) |
| ID (1) | ID27049A (https=) |
| MY (1) | MY121864A (https=) |
| NO (1) | NO20005434L (https=) |
| PL (1) | PL343637A1 (https=) |
| RU (1) | RU2224760C2 (https=) |
| SK (1) | SK15972000A3 (https=) |
| TR (1) | TR200003144T2 (https=) |
| TW (1) | TWI232220B (https=) |
| UA (1) | UA66856C2 (https=) |
| WO (1) | WO1999055708A1 (https=) |
| ZA (1) | ZA200006994B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19928146A1 (de) | 1999-06-19 | 2000-12-21 | Merck Patent Gmbh | Thienopyrimidine |
| DE19943815A1 (de) * | 1999-09-14 | 2001-03-15 | Merck Patent Gmbh | Verwendung von Thienopyrimidinen |
| DE19944604A1 (de) * | 1999-09-17 | 2001-03-22 | Merck Patent Gmbh | Aminderivate |
| WO2001051089A1 (de) * | 2000-01-13 | 2001-07-19 | Merck Patent Gmbh | Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler |
| DE10001021A1 (de) * | 2000-01-13 | 2001-07-19 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
| DE10010612A1 (de) * | 2000-03-03 | 2001-09-27 | Merck Patent Gmbh | Verwendung von PDE V-Inhibitoren |
| DE10017947A1 (de) * | 2000-04-11 | 2001-10-25 | Merck Patent Gmbh | Verfahren zur Herstellung benzo-annelierter Heterocyclen |
| DE10031585A1 (de) * | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 2-Aminoalkyl-thieno[2,3-d]pyrimidine |
| EP1347762A2 (de) * | 2000-12-19 | 2003-10-01 | MERCK PATENT GmbH | Pharmazeutische formulierung enthaltend thienopyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate (2) |
| DE10064994A1 (de) * | 2000-12-23 | 2002-07-04 | Merck Patent Gmbh | Sulfamidothienopyrimidine |
| HUP0302987A2 (hu) * | 2001-01-31 | 2003-12-29 | Merck Patent Gmbh | Pirazolo [4,3-d] pirimidinszármazékokat vagy tienopirimidinszármazékokat és nitrátvegyületeket tartalmazó gyógyászati készítmények |
| DE10107261B4 (de) * | 2001-02-16 | 2005-03-10 | Merck Patent Gmbh | Pharmazeutische Zusammensetzung |
| DE10148883A1 (de) * | 2001-10-04 | 2003-04-10 | Merck Patent Gmbh | Pyrimidinderivate |
| JPWO2003035653A1 (ja) * | 2001-10-26 | 2005-02-10 | 日本曹達株式会社 | ピリドチエノピリミジン化合物およびその塩 |
| US8207172B2 (en) * | 2004-08-20 | 2012-06-26 | Bayer Intellectual Property Gmbh | Pyrimidinothienoindazoles useful for the treatment of hyperproliferative disorders |
| ES2259891B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
| ES2259892B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
| JP2008536888A (ja) | 2005-04-19 | 2008-09-11 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肺高血圧症の治療のためのロフルミラスト |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2657760B2 (ja) | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | ４−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| PH31122A (en) * | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
| GB9311920D0 (en) * | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
| DK0640599T3 (da) | 1993-08-26 | 1998-09-28 | Ono Pharmaceutical Co | 4-Aminopyrimidin-derivater |
| US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
| DE19632423A1 (de) * | 1996-08-12 | 1998-02-19 | Merck Patent Gmbh | Thienopyrimidine |
| DE19644228A1 (de) | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine |
| DE19752952A1 (de) | 1997-11-28 | 1999-06-02 | Merck Patent Gmbh | Thienopyrimidine |
-
1998
- 1998-04-29 DE DE19819023A patent/DE19819023A1/de not_active Withdrawn
-
1999
- 1999-04-23 ES ES99919263T patent/ES2255754T3/es not_active Expired - Lifetime
- 1999-04-23 AT AT99919263T patent/ATE314374T1/de not_active IP Right Cessation
- 1999-04-23 CZ CZ20003976A patent/CZ291109B6/cs not_active IP Right Cessation
- 1999-04-23 EP EP99919263A patent/EP1084125B1/de not_active Expired - Lifetime
- 1999-04-23 DE DE59912986T patent/DE59912986D1/de not_active Expired - Lifetime
- 1999-04-23 CA CA002328280A patent/CA2328280C/en not_active Expired - Fee Related
- 1999-04-23 JP JP2000545867A patent/JP4242561B2/ja not_active Expired - Fee Related
- 1999-04-23 BR BR9910032-0A patent/BR9910032A/pt not_active IP Right Cessation
- 1999-04-23 ID IDW20002463A patent/ID27049A/id unknown
- 1999-04-23 RU RU2000129659/04A patent/RU2224760C2/ru not_active IP Right Cessation
- 1999-04-23 HU HU0101832A patent/HUP0101832A3/hu unknown
- 1999-04-23 TR TR2000/03144T patent/TR200003144T2/xx unknown
- 1999-04-23 US US09/674,269 patent/US6495557B1/en not_active Expired - Fee Related
- 1999-04-23 CN CNB998054569A patent/CN1142936C/zh not_active Expired - Fee Related
- 1999-04-23 SK SK1597-2000A patent/SK15972000A3/sk unknown
- 1999-04-23 PL PL99343637A patent/PL343637A1/xx unknown
- 1999-04-23 WO PCT/EP1999/002738 patent/WO1999055708A1/de not_active Ceased
- 1999-04-23 AU AU37098/99A patent/AU743230B2/en not_active Ceased
- 1999-04-23 KR KR1020007011314A patent/KR20010042628A/ko not_active Ceased
- 1999-04-23 UA UA2000116687A patent/UA66856C2/uk unknown
- 1999-04-27 MY MYPI99001670A patent/MY121864A/en unknown
- 1999-04-28 AR ARP990101960A patent/AR016233A1/es unknown
- 1999-04-29 CO CO99025993A patent/CO5011050A1/es unknown
- 1999-04-29 TW TW088106948A patent/TWI232220B/zh not_active IP Right Cessation
-
2000
- 2000-10-27 NO NO20005434A patent/NO20005434L/no not_active Application Discontinuation
- 2000-11-28 ZA ZA200006994A patent/ZA200006994B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR016233A1 (es) | Tienopirimidinas, un procedimiento para su preparacion, el empleo de las mismas para preparar un medicamento, las composiciones farmaceuticas que lascontienen, y un procedimiento para obtener estas composiciones farmaceuticas. | |
| CY1119148T1 (el) | Φαρμακευτικες συνθεσεις και συναφεις μεθοδοι χορηγησης | |
| ES2084944T3 (es) | Amidas terapeuticas. | |
| MX9400060A (es) | Derivados ester del hexahidronaftaleno, su preparacion y sus usos terapeuticos. | |
| AR010962A1 (es) | Tienopirimidinas, un procedimiento para su preparacion, empleo de las mismas para preparar un medicamento, preparaciones farmaceuticas que lascontienen, y un procedimiento para obtener estas preparaciones farmaceuticas. | |
| BRPI0411863A (pt) | derivados de pirazolil-indol como inibidores de cinase, processo para seu preparo e composições farmacêuticas compreendendo os mesmos | |
| CY1107081T1 (el) | Λιπαρα οξεα, ως παραγοντες επιβιωσης κι ενεργοποιησης ουδετεροφιλων | |
| AR036448A1 (es) | Composiciones farmaceuticas de conjugados droga insulina-oligomeros, y metodos para tratar las enfermedades con los mismos | |
| AR009985A1 (es) | Aminotiofencarboxamidas, un procedimiento para su preparacion, empleo de las mismas para preparar un medicamento, preparaciones farmaceuticas que lascontienen, y un procedimiento para obtener estas preparaciones farmaceuticas | |
| BR0011823A (pt) | Derivado de benzimidazol, composto, composição farmacêutica, uso de um derivado de benzimidazol, e, método para tratamento, prevenção ou alìvio de uma doença ou de um distúrbio ou de uma condição de um corpo animal vivo | |
| ES2063011T3 (es) | Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente. | |
| CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| AR023971A1 (es) | Derivados de 4,5,6,7-tetrahidroindazol, procedimiento para la preparacion de los mismos y su utilizacion como agentes antitumorales | |
| AR033346A1 (es) | Acido aminoalcano carboxilicos, un procedimiento para su preparacion, intermediarios, y el uso de los mismos para la manufactura de un medicamento | |
| ATE82684T1 (de) | Mittel zur behandlung und zum schutz der haut. | |
| ECSP045140A (es) | Formulaciones farmacéuticas derivadas del platino | |
| ECSP056246A (es) | DERIVADOS DE PIRROLO [3,4-c]PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA | |
| AR050261A2 (es) | Aminoacidos con afinidad por la proteina alfa-2-delta y composiciones farmaceuticas que los contienen y su uso para preparar un medicamento | |
| ES2077199T3 (es) | Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| AR015448A1 (es) | COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN | |
| EE200200565A (et) | Vaskulaarse kahjustava toimega kombinatsioonravi | |
| ES2063570T3 (es) | Nuevos derivados de triazolopirimidina antagonistas de los receptores de la angiotensina ii; sus procedimientos de preparacion, composiciones farmaceuticas que los contienen. | |
| US20170049804A1 (en) | Fast acting joint relief formulations | |
| AR012723A1 (es) | Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos | |
| UY23844A1 (es) | Agentes antivirosicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |